ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
Director Paul Schimmel sold $4.2M of Alnylam Pharmaceuticals, Inc.
Sold$4,173,450
$150.00Price
27,823Shares
−8%Stake
What ALNY did after the filing
- The stock from Wed, Mar 14 close, $141.83
- −32.8%
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Apr 26 close.
Traded Tue, Mar 13. Filed Wed, Mar 14, 3:39 PM ET, during the session. Returns use the Mar 14 close and the Apr 26 close. Not investment advice.